Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause International normalised ratio fluctuation? 5 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of International normalised ratio fluctuation have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.

5
Reports of International normalised ratio fluctuation with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
3
Hospitalizations

How Dangerous Is International normalised ratio fluctuation From SECUKINUMAB?

Of the 5 reports, 3 (60.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.

Is International normalised ratio fluctuation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause International normalised ratio fluctuation?

WARFARIN (738) ADALIMUMAB (167) METHOTREXATE (159) BISOPROLOL (155) LEFLUNOMIDE (150) CELECOXIB (149) LEVOFLOXACIN (149) NORFLOXACIN (149) PREDNISONE (149) CEFACLOR (148)

Which SECUKINUMAB Alternatives Have Lower International normalised ratio fluctuation Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All International normalised ratio fluctuation Reports All Drugs Causing International normalised ratio fluctuation SECUKINUMAB Demographics